April 8, 2021
Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions
Combination of Philips’ digital pathology solutions and Ibex’s AI-powered Galen platform has improved reporting efficiency by 27%, driven 37% productivity gains, and improved consistency and accuracy to enhance diagnostic confidence
Collaboration furthers Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis
Amsterdam, The Netherlands and Tel Aviv, Israel –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and
Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, today announced a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide. The combination of Philips digital pathology solution (